BioXcel Therapeutics
BTAI
BTAI
103 hedge funds and large institutions have $388M invested in BioXcel Therapeutics in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 50 increasing their positions, 25 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
5% less funds holding
Funds holding: 108 → 103 (-5)
29% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 17
Holders
103
Holding in Top 10
–
Calls
$6.54M
Puts
$6.84M
Top Buyers
| 1 | +$20.4M | |
| 2 | +$5.67M | |
| 3 | +$3.94M | |
| 4 |
BlackRock
New York
|
+$2.56M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$2.34M |
Top Sellers
| 1 | -$7.62M | |
| 2 | -$6.75M | |
| 3 | -$6.22M | |
| 4 |
LM
Luminus Management
Houston,
Texas
|
-$4.57M |
| 5 |
Blackstone Inc
New York
|
-$4.36M |